Introduction
============

Chronic pain has major adverse effects on health-related quality of life and contributes to significant socioeconomic burden.[@b1-jpr-11-629] The severity of pain leads to usage of health care and absence from work.[@b2-jpr-11-629],[@b3-jpr-11-629] Chronic postsurgical pain (CPSP) is defined as persistent pain that develops after a surgical procedure and lasts for at least 3 months with other causes of pain excluded.[@b4-jpr-11-629] The incidence of CPSP could be up to 50%--60% depending on the type of surgery.[@b4-jpr-11-629],[@b5-jpr-11-629] High-risk surgeries, such as thoracic, amputation, mastectomy, and cardiac surgery,[@b6-jpr-11-629]--[@b9-jpr-11-629] commonly lead to CPSP. Unfortunately, even simple minor procedures, for example, hernia repair and cholecystectomy have marked risk of developing CPSP.[@b5-jpr-11-629]

Hysterectomy is a commonly performed gynecological procedure that is associated with chronic post-hysterectomy pain (CPHP), with a reported incidence of 14%--50%.[@b10-jpr-11-629]--[@b12-jpr-11-629] Risk factors have been suggested for the development of CPSP, including surgical technique, genetic susceptibility, significant perioperative pain, psychological factors, age, and female gender.[@b13-jpr-11-629],[@b14-jpr-11-629]

Central sensitization is widely recognized as one of the major risk factors associated with chronic pain development. Central sensitization is defined as the increased responsiveness of nociceptive neurons in the central nervous system to their normal or subthreshold afferent input.[@b15-jpr-11-629] Difference in the central process of peripheral tissue damages was believed to be one of the factors responsible for wide variability in pain perception. Higher mechanical temporal summation had been shown to predict acute provoked pain after thoracotomy, suggesting central pain augmentation or sensitization.[@b16-jpr-11-629],[@b17-jpr-11-629] However, few studies have associated preoperative physical testing with CPSP.[@b18-jpr-11-629]

In this study, we aimed to investigate women who were scheduled for elective abdominal or laparoscopic hysterectomy. Spielberger's State--Trait Anxiety Inventory (STAI), Pain Catastrophizing Scale (PCS), preoperative surveys, and mechanical temporal summation physical pain test were conducted prior to the surgery. Phone surveys at 4 and 6 months after hysterectomy were also performed to identify demographic, psychological, and perioperative association factors for the development of CPHP.

By identifying the association factors for CPHP, the results of this study could elucidate potential mechanisms of CPSP development that will guide us in risk stratification and targeted therapy, such as minimizing injuries to peripheral sensory nerves by laparoscopic surgeries, cognitive behavior therapy or counseling for psychosocial factors, and ensuring adequate perioperative pain control.[@b19-jpr-11-629]

Materials and methods
=====================

This is a prospective cohort study involving women who were scheduled for elective abdominal or laparoscopic hysterectomy for benign conditions at KK Women's and Children's Hospital, Singapore. The SingHealth Centralized Institutional Review Board approved the study (CIRB ref.: 2013/512/D), and informed written consent was obtained. This trial is registered at [Clinical.trials.gov](http://Clinical.trials.gov). (NCT02025153).

The inclusion criteria were American Society of Anesthesiologists status 1 and 2 women between 21 and 70 years of age who underwent abdominal or laparoscopic hysterectomy for benign conditions (fibroids, adenomyosis). The exclusion criteria included vaginal hysterectomy, failure to adequately determine mechanical temporal summation, gynecological conditions such as uterine prolapse, endometriosis, malignant disease, or any other with the main indication being pelvic pain, and history of drug dependence or recreational drug use.

Patients were asked to complete STAI, PCS, preoperative surveys, and mechanical temporal summation physical pain testing prior to the surgery. The STAI is a self-reported tool for assessing anxiety and consists of two subscales, each containing 20 items on a four-point rating scale. The state anxiety subscale measures transient anxiety at the moment of scoring. Trait anxiety measures dispositional anxiety or anxiety in general.[@b20-jpr-11-629] PCS contains 13 items which assess three components of catastrophizing: rumination, magnification, and helplessness, on a five-point scale.[@b21-jpr-11-629] Preoperative survey comprised questions related to demographic data, history of lower abdominal pain, previous surgical history, and medical comorbidities (hypertension, diabetes mellitus, hyperlipidemia, pre-existing depression, thyroid diseases).[@b22-jpr-11-629] Mechanical temporal summation is a dynamic test for central sensitization, associated with postoperative pain.[@b17-jpr-11-629],[@b23-jpr-11-629] Evoked mechanical temporal summation has been shown to predict acute provoked postoperative pain after thoracotomy, suggesting central pain augmentation or sensitization.

Intraoperative data such as use of analgesia were also recorded. After surgery, patients were asked to rate their pain scores (numerical rating scale: 0--10; 0=no pain, 10=worst pain imaginable) around the surgical scar at rest, when sitting at the edge of bed, and/or coughing, in the recovery area. The pain scores at postoperative 24, 48, and 72 hours were also collected in the ward.

Four- and 6-month postoperative phone surveys were conducted to assess the presence of CPHP and functional impairments. Each survey asked about pain duration in terms of "I don't know/I don't remember", "less than 1 month", "1--3 months", "more than 3 months, but not now", "I still have pain, ever since the operation", "I still have pain, it started sometime after the operation". In the 4-month pain survey, the primary outcome "patient is still in pain" was defined as follows: a patient mentioned any one of the last three options and with pain scores ≥3. Similarly, primary outcome in the 6-month survey was defined as a patient who selected any of the two above-mentioned options and with pain scores ≥3. Both outcomes of interest were treated as binary data with categories "yes" or "no".

Statistical analysis
--------------------

All categorical variables were presented as frequency with corresponding proportion, while all continuous variables were presented as mean±SD. The associations between outcomes and other categorical variables were evaluated using Fisher's exact test, while the associations between outcomes and continuous variables were assessed using Student's *t*-test. Univariate and multivariate logistic regression models were used to quantify the association between the potential covariates and the outcome of interest. The association from the logistic regression was characterized using odds ratio (OR) and corresponding 95% CI. Significance level was set at 0.05, and all tests were two-tailed. SAS version 9.3 software (SAS Institute, Cary, NC, USA) was used for the analysis.

Multivariate imputation using chained equations (MICE) is a practical approach to handle missing data.[@b24-jpr-11-629],[@b25-jpr-11-629] The imputation process has been described.[@b25-jpr-11-629] We assumed that missing data being missing at random (MAR). A polytomous regression imputation method was also used for the variables with more than two categories. MICE method imputes missing values in different steps. All missing values were filled at random and multiple imputed data sets were generated. For each one of the imputed variables, an imputation model was built, considering all variables that were included in the subsequent analysis, as well as those that might be predictive of the missing values. The imputed data sets were analyzed separately and all the independent estimations were combined into an overall estimate. We created 500 imputed data for each 4- and 6-month outcome of interest. MICE package in R-software was used to perform the imputation of pain at 4- and at 6-month.[@b21-jpr-11-629]

Results
=======

Two hundred sixteen women were recruited from September 2013 to January 2016 in this study ([Figure 1](#f1-jpr-11-629){ref-type="fig"}). Two hundred and fifty-five women were screened, 30 women did not give consent for this study, and nine women did not meet the inclusion criteria. The response rates on the phone surveys at 4- and 6-months were 81.0% (175/216) and 73.6% (159/216), respectively. A total of 175 and 159 patients were included in the final analysis at 4- and 6-month phone surveys, respectively. [Figure 1](#f1-jpr-11-629){ref-type="fig"} shows the flow chart of the study.

Baseline characteristics and comparisons are summarized in [Table 1](#t1-jpr-11-629){ref-type="table"}. Age, race, educational level, housing type, alcohol use, smoking, history of previous surgery (cesarean section, laparotomy, or laparoscopy), comorbidity (hypertension, diabetes mellitus, hyperlipidemia, pre-existing depression, thyroid diseases), types of surgery (laparotomy or laparoscopic hysterectomy), and postoperative complications were not associated with CPHP at 4- and 6-month follow-up ([Table 1](#t1-jpr-11-629){ref-type="table"}).

[Table 2](#t2-jpr-11-629){ref-type="table"} shows the comparison of perioperative events between patients with CPHP and those without CPHP at postoperative 4 and 6 months. Of the 175 patients who responded to the 4-month phone survey, 32% (56/175) reported persistent post-hysterectomy (CPHP) pain (numerical rating scale ≥3) for at least 4 months. The incidence of CPHP at 6 months was decreased to 15.7% (25/159). Based upon univariate analysis, patients with CPHP at 4 months were associated with higher pain score at the recovery room (*p*=0.001) and at 24 hours postoperatively when resting (*p*=0.015), higher PCS scores (*p*=0.011), especially rumination (*p*=0.020) and helplessness (*p*=0.017) subscores, as well as higher STAI total score (*p*=0.031) and trait anxiety scores (*p*=0.029). Women with CPHP at 6 months were associated with higher pain scores at the recovery room (*p*=0.008) and higher PCS scores (*p*=0.008), especially rumination (*p*=0.027) and helplessness (*p*=0.015) scores ([Table 2](#t2-jpr-11-629){ref-type="table"}).

Women who developed CPHP at 4 and 6 months had pain that caused significant functional impairment in daily living. As shown in [Table 3](#t3-jpr-11-629){ref-type="table"}, of the 56 patients who reported persistent pain at 4-month survey, 38.2% reported pain affecting certain daily activities (*p*\<0.001) such as getting up from a chair, prolonged sitting or standing, walking up or down stairs, and carrying heavy objects ([Table 3](#t3-jpr-11-629){ref-type="table"}). At the 6-month survey, of the 25 women who reported persistent pain, 24% reported pain that interfered with their sleep (*p*=0.031) and 44% reported pain affecting their daily activities (*p*\<0.001) such as getting up from a chair and carrying heavy objects ([Table 3](#t3-jpr-11-629){ref-type="table"}).

Possible risk factors were considered in the multivariate logistic regression model to identify independent risk factors for persistent post-hysterectomy pain. The analysis results based on complete case data showed that higher mechanical temporal summation (OR 1.064, *p*=0.0002), higher pain score at the recovery room (OR 1.389, *p*=0.0153), 24-hour pain score while coughing (OR 1.135, *p*=0.0201), postoperative 24-hour itching (OR 3.327, *p*=0.0273), and preoperative lower abdominal pain (OR 8.546, *p*=0.0044) were associated with CPHP at 4 months ([Table 4](#t4-jpr-11-629){ref-type="table"}). Similarly, the independent risk factors for CPHP at 6 months on multivariate logistic regression based on complete data were higher mechanical temporal summation score (OR 1.078, *p*\<0.001), preoperative experience of pain during sexual intercourse (OR 5.312, *p*=0.0158), and postoperative morphine consumption during 24--48 hours postoperatively (OR 1.172, *p*=0.0196; [Table 5](#t5-jpr-11-629){ref-type="table"}). Multivariate analysis based on the imputed data set produced similar results in terms of association between post-hysterectomy pain at 4 and 6 months, respectively.

Discussion
==========

In our prospective cohort study in the Asian population, we investigated the development of CPHP at 4 and 6 months and found the incidence of CPHP to be 32% (56/175) and 15.7% (25/159), respectively. Women with CPHP at 4 and 6 months had pain that interfered with their activities of daily living. Several independent association factors were found, and most of the patients with CPHP had resolution of their pain at 6 months.

CPSP is an underappreciated chronic pain condition that has gained increasing attention, and several studies have reported varying incidence rates. Brandsborg et al previously reported that the incidence of CPHP at 4 months was 16.7%, which is lower than our result (32.0% \[56/175\]).[@b12-jpr-11-629],[@b18-jpr-11-629] It is interesting that Pokkinen et al found the incidence of CPHP at 6 months to be 26.0%, which is higher than our result (15.7%).[@b10-jpr-11-629] Han et al described the incidence of CPHP at 3 months to be 27.7%, comparable with our finding.[@b26-jpr-11-629] However, these studies only conducted a post-hysterectomy pain survey at one time point. Nevertheless, this study found that the incidence of CPHP decreased with time, suggesting the resolution of CPHP over time.

Women with CPHP reported significant functional limitations affecting their activities of daily living and sleep. This study also identified several significant association factors of CPHP development, such as experience of pain during sexual intercourse, higher mechanical temporal summation score, higher pain catastrophizing helplessness subscores preoperatively, higher intraoperative morphine consumption, and higher pain score in the immediate postoperative period. Hence, pain and psychological vulnerability could be important association factors with CPHP.

Higher mechanical temporal summation score and higher morphine consumption were independently associated with CPHP at 4 and at 6 months. Mechanical temporal summation is a dynamic test for central sensitization, which is associated with postoperative pain. Higher mechanical temporal summation has been shown to predict acute provoked pain after thoracotomy, suggesting central pain augmentation or sensitization.[@b17-jpr-11-629],[@b27-jpr-11-629] Such sensitization could be associated with nerve injury following surgical intervention. However, there is currently limited evidence of the association between mechanical temporal summation and chronic pain development.[@b16-jpr-11-629] Our study suggests that the use of mechanical temporal summation could be associated with CPSP development, though more studies would be needed to validate this.

The roles of psychological factors such as anxiety, depression, and dysfunctional pain coping mechanism in the development of CPSP have been controversial.[@b28-jpr-11-629]--[@b31-jpr-11-629] Pinto et al also found that pain catastrophizing, particularly helplessness subscore, could play an important role in pain development.[@b11-jpr-11-629] This suggests that cognitive-affective therapy (cognitive behavior therapy, mindfulness therapy) could be an important target for treatment for CPHP. Of note, our study did not find an association of anxiety with CPHP.

Surgical nerve injury and neuropathic pain development could be one of the underlying causes of CPSP, thus leading to efforts to minimize nerve injury during surgery.[@b13-jpr-11-629] Laparoscopic inguinal herniotomy and cholecystectomy are associated with lower CPSP, compared to the open approach.[@b32-jpr-11-629]--[@b34-jpr-11-629] However, our study did not demonstrate this. Meltomaa et al[@b35-jpr-11-629] also found that laparoscopy or laparotomy hysterectomy did not differ in CPHP incidence, suggesting deep visceral surgical injury to be the predominant factor. The association of acute postoperative pain intensity with chronic pain development was consistent with several previous studies;[@b36-jpr-11-629]--[@b38-jpr-11-629] therefore, implementation of early, aggressive therapy for acute postoperative pain could reduce CPHP. Alternative therapy avoiding surgery could be considered for benign conditions.[@b39-jpr-11-629],[@b40-jpr-11-629] The minimally invasive uterine artery embolization has shown a good clinical success rate in reducing fibroid size.[@b41-jpr-11-629]

There are several limitations in this study. The assessment of possible confounding factors could be limited. We used available potential confounders such as diabetes mellitus, hypertension, dyslipidemia, and mood disorders that could be potential confounders. However, there could be unknown association factors not accounted for in our study design. The second limitation is that endometriosis, which is one of the most common gynecological diseases, was not studied.[@b42-jpr-11-629],[@b43-jpr-11-629] We felt that since endometriosis is associated with existing chronic pelvic pain condition, this could make the interpretation of our data difficult. Only females were recruited in this study; therefore, the effect of gender difference on CPSP cannot be evaluated. However, hysterectomy is a very common surgical procedure, making the disease burden very high. In addition, our study population was mainly Asian and this might not represent other populations, as pain could be influenced by ethnic and cultural differences.

In summary, the majority of CPHP cases recovered with time, but CPHP is associated with significant impact on activities of daily living. Independent association factors for CPHP include higher mechanical temporal summation scores and increased pain scores in the immediate postoperative period. Hence, these could be further investigated and modification in therapy could be targeted in these higher risk patients.
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###### 

Comparison of baseline characteristics at 4 and 6 months

  Characteristics                               Postoperative follow-up at                                                  
  --------------------------------------------- ---------------------------- ------------ ------- ------------ ------------ -------
  Age, mean±SD                                  48.6±5.28                    49.0±6.54    0.665   48.7±5.98    48.9±6.35    0.853
  BMI, mean±SD                                  26.2±5.47                    26.4±5.22    0.819   27.3 (6.0)   26.2 (5.3)   0.330
  Race, n (%)                                                                             0.279                             0.802
   Chinese                                      37 (66.1)                    89 (74.8)            18 (72.0)    101 (75.4)   
   Non-Chinese                                  19 (33.9)                    30 (25.2)            7 (28.0)     33 (24.6)    
  Education, n (%)                                                                        0.400                             0.465
   Primary                                      16 (28.6)                    23 (19.3)            6 (24.0)     29 (21.6)    
   Secondary                                    34 (60.7)                    80 (67.2)            18 (72)      86 (64.2)    
   Tertiary                                     6 (10.7)                     16 (13.4)            1 (4.0)      19 (14.2)    
  Housing, n (%)                                                                          0.386                             0.239
   Private                                      3 (5.4)                      3 (2.5)              2 (8.0)      4 (3.0)      
   Public                                       53 (94.6)                    116 (97.5)           23 (92.0)    130 (97.0)   
  Alcohol use, n (%)                            2 (3.6)                      0 (0)        NA      1 (4.0)      1 (0.7)      0.232
  Smoking, n (%)                                2 (3.6)                      7 (5.9)      0.523   1 (4.0)      8 (6.0)      0.698
  History of previous cesarean section, n (%)   16 (28.6)                    26 (21.8)    0.333   8 (32.0)     30 (22.4)    0.304
  History of previous laparotomy, n (%)         8 (14.3)                     18 (15.1)    0.884   4 (16.0)     22 (16.4)    0.959
  History of previous laparoscopy, n (%)        8 (14.3)                     20 (16.8)    0.672   4 (16.0)     21 (15.7)    0.967
  Comorbidity hypertension, n (%)               17 (30.4)                    33 (27.7)    0.720   8 (32.0)     38 (28.4)    0.713
  Comorbidity DM, n (%)                         7 (12.5)                     14 (11.8)    0.889   3 (12.0)     17 (12.7)    0.924
  Comorbidity dyslipidemia, n (%)               14 (25.0)                    23 (19.3)    0.392   5 (20.0)     29 (21.6)    0.854
  Pre-existing depression, n (%)                1 (1.8)                      4 (3.4)      0.566   1 (4.0)      3 (2.2)      0.611
  Thyroid disease, n (%)                        3 (5.4)                      5 (4.2)      0.733   1 (4.0)      6 (4.5)      0.915
  Type of surgery, n (%)                                                                  0.873                             0.665
   Laparotomy                                   29 (51.8)                    60 (50.4)            11 (44.0)    67 (50.0)    
   Laparoscopic                                 27 (48.2)                    59 (49.6)            14 (56.0)    67 (50.0)    
  Oophorectomy performed, n (%)                 41 (73.2)                    84 (71.2)    0.781   17 (68.0)    97 (72.9)    0.614
  Postoperative complications, n (%)            0 (0)                        5 (4.2)      NA      0 (0)        4 (3.0)      NA

**Note:** *p*-values are based on Student's *t*-test for continuous variables and Fisher's exact test for categorical variables.

**Abbreviations:** BMI, body mass index; CPHP, chronic post-hysterectomy pain; DM, diabetes mellitus; NA, not applicable.

###### 

Comparison of perioperative events at 4 and 6 months

  Characteristics                   Postoperative follow-up at                                                                                                 
  --------------------------------- ---------------------------- ------------ -------------------------------------------------- -------------- -------------- --------------------------------------------------
  Intraoperative morphine (mg)      9.1±2.12                     8.4±2.47     0.052                                              8.9**±2.98**   8.6**±2.30**   0.639
  Intraoperative fentanyl (mcg)     81.0±43.1                    82.1±40.4    0.866                                              78.4±40.79     83.2±40.99     0.592
  Recovery room pain score          2.3±1.43                     1.5±1.43     0.001[\*](#tfn4-jpr-11-629){ref-type="table-fn"}   2.3**±1.10**   1.6**±1.46**   0.008[\*](#tfn4-jpr-11-629){ref-type="table-fn"}
  24-hour pain score when resting   2.5±2.79                     1.5±1.91     0.015[\*](#tfn4-jpr-11-629){ref-type="table-fn"}   2.3**±2.67**   1.6**±2.05**   0.205
  Pain catastrophizing score        20.0±12.20                   14.9±11.64   0.011[\*](#tfn4-jpr-11-629){ref-type="table-fn"}   21.2±9.72      15.1±11.24     0.008[\*](#tfn4-jpr-11-629){ref-type="table-fn"}
  Rumination subscore               8.3±4.56                     6.6±4.11     0.020[\*](#tfn4-jpr-11-629){ref-type="table-fn"}   8.9±4.34       6.4±4.08       0.027[\*](#tfn4-jpr-11-629){ref-type="table-fn"}
  Helplessness subscore             7.6±6.21                     5.2±5.66     0.017[\*](#tfn4-jpr-11-629){ref-type="table-fn"}   3.9±2.45       3.2±2.83       0.015[\*](#tfn4-jpr-11-629){ref-type="table-fn"}
  Magnification subscore            4.1±3.14                     3.1±2.86     0.052                                              8.4±5.70       5.2±5.42       0.195
  STAI total score                  84.6±15.08                   79.2±15.61   0.031[\*](#tfn4-jpr-11-629){ref-type="table-fn"}   82.4±12.99     79.9±15.65     0.384
  State anxiety score               46.8±7.98                    44.6±9.90    0.114                                              45.1±8.26      45.0±9.59      0.956
  Trait anxiety score               37.8±8.65                    34.8±8.21    0.029[\*](#tfn4-jpr-11-629){ref-type="table-fn"}   37.4±6.38      35.0±8.43      0.111

**Notes:** All the values are expressed in terms of mean±SD. *p*-values are based on two-sample Student's *t*-test.

*p*-value\<0.05.

**Abbreviations:** CPHP, chronic post-hysterectomy pain; STAI, State--Trait Anxiety Inventory.

###### 

Functional impairment comparison at 4 and 6 months

  Characteristics                       Postoperative follow-up at                                                                                              
  ------------------------------------- ---------------------------- ------------ ---------------------------------------------------- ----------- ------------ ----------------------------------------------------
  Pain interfering with sleep           10 (18.2)                    9 (7.6)      0.064                                                6 (24.0)    5 (3.7)      0.031[\*](#tfn7-jpr-11-629){ref-type="table-fn"}
  Pain requiring medication             13 (23.6)                    8 (6.8)      0.005[\*](#tfn7-jpr-11-629){ref-type="table-fn"}     4 (16.0)    4 (3.0)      0.085
  Pain affecting daily living                                                     \<0.001[\*](#tfn7-jpr-11-629){ref-type="table-fn"}                            \<0.001[\*](#tfn7-jpr-11-629){ref-type="table-fn"}
   Not at all                           34 (61.8)                    108 (91.5)                                                        14 (56.0)   129 (96.3)   
   Some                                 18 (32.7)                    10 (8.5)                                                          9 (36.0)    5 (3.7)      
   A lot, very much                     3 (5.5)                      0                                                                 2 (8.0)     0            
  Pain from getting up from chair       15 (27.3)                    10 (8.5)     0.002[\*](#tfn7-jpr-11-629){ref-type="table-fn"}     8 (32.0)    4 (3.0)      0.004[\*](#tfn7-jpr-11-629){ref-type="table-fn"}
  Pain from sitting down \>30 minutes   16 (29.1)                    9 (7.6)      \<0.001[\*](#tfn7-jpr-11-629){ref-type="table-fn"}   2 (8.0)     2 (1.5)      0.093
  Pain from standing up \>30 minutes    19 (34.5)                    14 (11.9)    \<0.001[\*](#tfn7-jpr-11-629){ref-type="table-fn"}   6 (24.0)    12 (9.0)     0.252
  Pain from walking up or down stairs   16 (29.1)                    17 (14.4)    0.036[\*](#tfn7-jpr-11-629){ref-type="table-fn"}     6 (24.0)    10 (7.5)     0.393
  Pain from carrying heavy bags         30 (55.6)                    24 (21.1)    \<0.001[\*](#tfn7-jpr-11-629){ref-type="table-fn"}   19 (76.0)   23 (17.7)    \<0.001[\*](#tfn7-jpr-11-629){ref-type="table-fn"}

**Notes:** Values are expressed in terms of frequency (%). *p*-values are based on two-sample Fisher's test.

*p*-value\<0.05.

**Abbreviation:** CPHP, chronic post-hysterectomy pain.

###### 

Multivariate logistics regression analysis at 4 months

  Characteristics                                   Complete case          Imputed data                                                               
  ------------------------------------------------- ---------------------- --------------------------------------------------- ---------------------- ---------------------------------------------------
  Mechanical temporal summation                     1.064 (1.03--1.099)    0.0002[\*](#tfn9-jpr-11-629){ref-type="table-fn"}   1.055 (1.026--1.084)   0.0001[\*](#tfn9-jpr-11-629){ref-type="table-fn"}
  24-hour pain score when coughing                  1.135 (1.02--1.262)    0.0201[\*](#tfn9-jpr-11-629){ref-type="table-fn"}   1.125 (1.032--1.227)   0.0078[\*](#tfn9-jpr-11-629){ref-type="table-fn"}
  Recovery room pain score                          1.389 (1.065--1.811)   0.0153[\*](#tfn9-jpr-11-629){ref-type="table-fn"}   1.287 (1.034--1.602)   0.0241[\*](#tfn9-jpr-11-629){ref-type="table-fn"}
  Itching at 24-hour                                0.301 (0.103--0.874)   0.0273[\*](#tfn9-jpr-11-629){ref-type="table-fn"}   0.396 (0.166--0.94)    0.0357[\*](#tfn9-jpr-11-629){ref-type="table-fn"}
  Preoperative pain in the lower abdominal region   0.117 (0.027--0.513)   0.0044[\*](#tfn9-jpr-11-629){ref-type="table-fn"}   0.244 (0.075--0.795)   0.0192[\*](#tfn9-jpr-11-629){ref-type="table-fn"}

**Notes:**

*p*-value\<0.05. Complete case refers to patients with complete baseline assessment and 4-month postoperative survey.

**Abbreviation:** OR, odds ratio.

###### 

Multivariate logistics regression analysis at 6 months

  Characteristics                                 Complete case           Imputed data                                                                  
  ----------------------------------------------- ----------------------- ------------------------------------------------------ ---------------------- ----------------------------------------------------
  Mechanical temporal summation                   1.078 (1.041--1.117)    \<0.0001[\*](#tfn11-jpr-11-629){ref-type="table-fn"}   1.047 (1.021--1.074)   0.0003[\*](#tfn11-jpr-11-629){ref-type="table-fn"}
  Morphine consumption (mg) during 24--48 hours   1.172 (1.026--1.34)     0.0196[\*](#tfn11-jpr-11-629){ref-type="table-fn"}     1.127 (1.027--1.237)   0.0118[\*](#tfn11-jpr-11-629){ref-type="table-fn"}
  Preoperative pain during sexual intercourse     5.312 (1.369--20.612)   0.0158[\*](#tfn11-jpr-11-629){ref-type="table-fn"}     3.175 (1.206--8.360)   0.0193[\*](#tfn11-jpr-11-629){ref-type="table-fn"}

**Notes:**

*p*-value\<0.05. Complete case refers to patients with complete baseline assessment and 6-month postoperative survey.

**Abbreviation:** OR, odds ratio.
